Work

Phase Ib/ II Study of Preliminary Efficacy, Safety and Pharmacodynamics of MG ‐ K10 , a Humanised Monoclonal Antibody Targeting IL ‐ 4Rα , in Adult Chinese Patients With Asthma

Year: 2026

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Clinical & Experimental Allergy

DOI: 10.1111/cea.70345

Authors: Mo Xian, Xu Shi, Ruoran Li, Li Zhao, Bing Zhuan, Bi Chen, Hanbing Shi, Zaiyi Wang, Feng Wu, Jian Guo, Yousheng Chen, Wei Dang, Jinlin Guo, Di Qin, Chenghai Zhang, Jing Li, Nanshan Zhong

Institutions: First Affiliated Hospital of Guangzhou Medical University, Xuzhou Central Hospital, Sheng Jing Hospital, China Medical University, Ningxia Hui Autonomous Region Peoples Hospital, Xuzhou Medical College, Affiliated Hospital of Xuzhou Medical College, Qiqihar Medical University, Xinjiang Medical University, First Affiliated Hospital of Xinjiang Medical University, Northern Jiangsu People's Hospital, Yangzhou University, Shanghai Pulmonary Hospital, Shanghai Mabgeek Biotech Co., Ltd. (China), Central Hospital of Zibo

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162795282

FWCI:

Cites: 23

Cited by:

Related to: